FDA Drug Application (017060) for NOR-QD by APIL

Back to FDA Applications sponsored by APIL

Application Number017060
Product Number001
FormTABLET;ORAL-28
Dosage0.35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNOR-QD
Active IngredientNORETHINDRONE



Back to FDA Applications sponsored by APIL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.